What You’ll Find in This Resource

Key Takeaways

About the Data

This summary is based on whole exome sequencing (WES) tests ordered through 3billion between November 2019 and April 2025.
Insights are drawn from phenotypes provided by clinicians and analyzed against confirmed positive diagnoses in European patients.